MONTREAL, Dec. 10, 2025 /CNW/ - Novartis Canada is pleased to announce that Scemblix ® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario's new Funding ...
The U.S. House of Representatives has given a unanimous thumbs-up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...
Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of "priority vouchers" for expedited drug approvals, suggesting that the voucher program ...
President Trump and FIFA President Gianni Infantino on Monday announced expedited visa processing for individuals attending next year’s FIFA World Cup in the U.S. Speaking in the Oval Office next to ...
Abstract: The second generation of robot operating system (ROS 2) received significant attention from the real-time system research community, mostly aiming at providing formal modeling and timing ...
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities. Rare and infectious ...
On Thursday, the U.S. Food and Drug Administration (FDA) announced six additional awardees under the Commissioner's National Priority Voucher (CNPV) pilot program. The second cohort brings the total ...
The CNPV program shortens FDA review times to 1-2 months, enhancing collaboration and expediting access to transformative therapies. Dompé will use the voucher for an intranasal nerve growth factor ...
A gene therapy for hearing loss. A drug that helps people quit e-cigarettes or vaping. An anesthetic whose main ingredient will be manufactured in the U.S. These are among the first nine therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results